Juvéderm Vollure XC is an injectable filler in the Juvederm collection. It gained FDA approval in the United States in 2017. It is now the first and only hyaluronic acid dermal filler approved for the correction of moderate to severe wrinkles and folds (such as nasolabial folds) that lasts up to 18 months in people over the age of 21.
Juvéderm Vollure XC features the same Vycross technology that Juvéderm Voluma XC and Juvéderm Volbella XC uses. However, it is FDA-approved to use the Vycross technology in the nasolabial folds, which also happens to be the number-one dermal treatment area.
Aging, genetics, and environmental factors like sun exposure can cause parentheses lines to become more visible. This dermal filler subtly smooths these lines to deliver results that last.